Measuring daily activity in people with CMT1A using a sensor
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study uses a small wearable sensor (like a fitness tracker) to see how active you are at home during your daily life. The goal is to better understand how CMT1A affects movement, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of CMT1A (a genetic test shows the PMP22 gene change).
- You are able to walk on your own, with or without aids like a cane or walker.
- You receive care at the University Hospital in Limoges or have had a walking analysis there.
- You are covered by the French national health insurance (sécurité sociale).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
This study uses a small device called ActivPal clipped to your leg to measure how much you move during daily life. Researchers want to compare activity levels between people with neuromuscular disorders and healthy volunteers to better understand physical activity patterns.
This study looks at how fatigue affects walking and balance in people with Charcot-Marie-Tooth type 1A. It compares patients with healthy volunteers to understand the impact. Participants will do walking and balance tests, and an exercise session on a stationary bike.
This study tests a portable device that analyzes walking without markers. It aims to see if it can help assess walking in people with neuromuscular diseases and healthy volunteers, which could lead to simpler check-ups.
This study is looking for people with Charcot-Marie-Tooth disease (a nerve condition) and healthy volunteers to track long-term changes in the body. Researchers want to see if certain biomarkers (measurable signs) can help predict how CMT progresses over time.
This study uses a small wearable sensor to measure walking and movement in people with Huntington's disease and healthy volunteers. It aims to find better ways to monitor the disease, which could help improve future care.
Hear when a new Motor Activity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.